Abstract
Central retinal artery occlusion (CRAO) is considered to be an acute stroke of the eye that results in profound visual loss. Spontaneous recovery rates are poor. Most CRAOs are caused by thromboembolism in the central retinal artery. Current standard therapies for CRAO that aim to restore perfusion to the retina and optic nerve head have not been shown to alter the natural course of the disease. Thrombolytic therapy for acute management of CRAO has shown promise in nonrandomized studies with regard to improving visual outcomes. A randomized controlled trial will be required to confirm the efficacy of thrombolytic therapy before it can be recommended for use in CRAO in daily clinical practice.
Key Points
-
Central retinal artery occlusion (CRAO) is considered to be an acute stroke of the eye that involves hypoperfusion to the retina and optic nerve head and leads to a reduction in visual function
-
CRAO has a poor spontaneous recovery rate
-
Current standard therapies for CRAO have not conclusively been shown to change the natural course of the disease
-
Local intra-arterial fibrinolysis shows promise in nonrandomized studies for the treatment of CRAO, but a randomized controlled trial will be required to demonstrate efficacy before this treatment can be considered for use in standard clinical practice
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hayreh SS and Zimmerman MB (2005) Central retinal artery occlusion: visual outcome. Am J Ophthalmol 140: 376–391
Hayreh SS (1995) The 1994 Von Sallman Lecture: the optic nerve head circulation in health and disease. Exp Eye Res 61: 259–272
Chia EM et al. (2003) Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br J Ophthalmol 87: 392–395
Vu HTV et al. (2005) Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 89: 360–363
Recchia FM and Brown GC (2000) Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 11: 462–467
Duker JS (2004) Retinal artery obstruction. In Ophthalmology, edn 2, 854–858 (Eds Yanoff M et al.) St Louis: Mosby
Mangat HS (1995) Central retina artery occlusion. Surv Ophthalmol 40: 145–156
Babikian V et al. (2001) Retinal ischemia and embolism, etiologies and outcomes based on a prospective study. Cerebrovasc Dis 12: 108–113
Lorentzen SE (1970) Incidence of cilioretinal arteries. Acta Ophthalmol (Copenh) 48: 518–524
Rumelt S and Brown GC (2003) Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol 14: 139–141
Savino PJ et al. (1977) Retinal stroke: is the patient at risk? Arch Ophthalmol 95: 1185–1189
Wong TY and Klein R (2002) Retinal arteriolar emboli: epidemiology and stroke risk. Curr Opin Ophthalmol 13: 142–146
Biousse V (2005) Cerebrovascular disease. In Walsh and Hoyt's Clinical Neuro-Ophthalmology, 1967–2168 (Eds Miller NR et al.) Philadelphia: Lippincott, Williams & Wilkins
Schmidt D et al. (2005) Retinal arterial occlusion due to embolism of suspected cardiac tumors—report on two patients and review of the topic. Eur J Med Res 10: 296–304
Sharma S et al. (1997) Transthoracic echocardiography in young patients with acute retinal arterial obstruction. RECO Study Group. Retinal Emboli of Cardiac Origin Group. Can J Ophthalmol 32: 38–41
Mokhtari F et al. (2000) Central retinal artery occlusion associated with head or neck pain revealing spontaneous internal carotid artery dissection. Am J Ophthalmol 129: 108–109
Schmidt D et al. (2007) Systemic diseases in non-inflammatory branch and central retinal artery occlusion: an overview of 416 patients. Eur J Med Res 12: 595–603
Fraser S and Siriwardena D . Interventions for acute non-arteritic central retinal artery occlusion. Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD001989. 10.1002/14651858.CD001989
Ffytche TJ (1974) A rationalization of treatment of central retinal artery occlusion. Trans Ophthalmol Soc UK 94: 468–479
Atebara NH et al. (1995) Efficacy of anterior chamber paracentesis and carbogen in treating acute nonarteric central retinal artery occlusion. Ophthalmology 102: 2029–2035
Wenzler EM et al. (1993) Hyperhomocysteinemia in retinal artery and retinal vein occlusion. Am J Ophthalmol 115: 162–167
Betram B et al. (1995) Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 4: 332–335
Rumelt S and Rehany U (1999) Central retinal artery occlusion associated with primary antiphospholipid syndrome. Eye 13: 699–700
Liem RI et al. (2008) Sudden-onset blindness in sickle cell disease due to retinal artery occlusion. Pediatr Blood Cancer 50: 624–627
Cohen RJ et al. (1995) Central retinal artery occlusion in a child with T-cell lymphoma. Am J Ophthalmol 120: 118–120
Chawluk JB et al. (1988) Atherosclerotic carotid artery disease in patients with retinal ischemic syndromes. Neurology 38: 858–863
Costello F et al. (2005) Bilateral simultaneous central retinal artery occlusions in Wegener granulomatosis. J Neuroophthalmol 25: 29–32
Lee DH et al. (1996) Sudden unilateral visual loss and brain infarction after autologous fat injection into the nasolabial groove. Br J Ophthalmol 80: 1026–1027
Egbert JE et al. (1996) Diagnosis and treatment of an ophthalmic artery occlusion during intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol 121: 638–642
Grossman W and Ward WT (1993) Central retinal artery occlusion after scoliosis surgery with a horseshoe headrest: case report and literature review. Spine 18: 1226–1228
Bekar A et al. (1996) Unilateral blindness due to patient postioning during cervical syringomyelia surgery: unilateral blindness after prone positioning. J Neurosurg Anesthesiol 8: 227–229
American Society of Anesthesiologists Task Force on Perioperative Blindness (2006) Practice advisory for perioperative visual loss associated with spine surgery: a report by the American Society of Anesthesiologists Task Force on Perioperative Blindness. Anesthesiology 104: 1319–1328
Vinerovsky A et al. (2004) Central retinal artery occlusion after peribulbar anesthesia. J Cataract Refract Surg 30: 913–915
Hayreh SS et al. (2004) Central retinal artery occlusion: retinal survival time. Exp Eye Res 78: 723–736
Hayreh SS et al. (1980) Central retinal artery occlusion and retinal tolerance time. Ophthalmology 87: 75–78
Hayreh SS (2005) Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24: 493–519
Augsburger JJ and Magargal LE (1980) Visual prognosis following treatment of acute central retinal artery occlusion. Br J Ophthalmol 64: 913–917
Connolly BP et al. (2000) Characteristics of patients presenting with central retinal artery occlusion with and without giant cell arteritis. Can J Ophthalmol 35: 379–384
Schmidt DP et al. (2002) Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. AJNR Am J Neuroradiol 23: 1301–1307
Beatty S and Au-Eong KG (2000) Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data. Br J Ophthalmol 84: 914–916
Rosser DA et al. (2003) How sensitive to clinical change are ETDRS logMAR visual acuity measurements? Invest Ophthalmol Vis Sci 44: 3278–3281
Rumelt S et al. (1999) Aggressive systematic treatment for central retinal artery occlusion. Am J Ophthalmol 128: 733–738
Harino S et al. (1995) Rebreathing into a bag increases human retinal macular blood velocity. Br J Ophthalmol 79: 380–383
Deutsch TA et al. (1983) Effects of oxygen and carbon dioxide on the retinal vasculature in humans. Arch Ophthalmol 101: 1278–1280
Incandela L et al. (2002) Treatment of vascular retinal disease with pentoxifylline: a controlled, randomized trial. Angiology 53 (Suppl 1): S31–S34
Beiran I et al. (2001) Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol 11: 345–350
Rassam SM et al. (1993) The effect of acetazolamide on the retinal circulation. Eye 7: 697–702
Landa E et al. (2004) Visual functions following recovery from non-arteritic central retinal artery occlusion. Ophthalmic Surg Lasers Imaging 35: 103–108
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333: 1581–1588
Furlan A et al. (1999) Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: prolyse in acute cerebral thromboembolism. JAMA 282: 2003–2011
Waters RE Jr et al. (2003) Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. Am Heart J 146: 958–968
Arnold M et al. (2005) Comparison of intra arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion. J Neurol Neurosurg Psychiatry 76: 196–199
Schumacher M et al. (1993) Intra-arterial fibrinolytic therapy in central retinal artery occlusion. Neuroradiology 35: 600–605
Kattah JC et al. (2002) Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol 120: 1234–1236
Butz B et al. (2003) Selective intraarterial fibrinolysis of acute central retinal artery occlusion. Acta Radiol 44: 680–684
Richard G et al. (1999) Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. Ophthalmology 106: 768–773
Suri MF et al. (2007) Intra-arterial thrombolysis for central retinal artery occlusion in United States: Nationwide In-patient Survey 2001–2003. J Neuroimaging 17: 339–343
Arruga J and Sanders MD (1982) Ophthalmic findings in 70 patients with evidence of retinal embolism. Ophthalmology 89: 1336–1337
Biousse V et al. (2007) Thrombolysis for central retinal artery occlusion. J Neuroophthalmol 21: 215–230
Aldrich E et al. (2008) Local intraarterial fibrinolysis administered in aliquots for the treatment of central retinal artery occlusion: the Johns Hopkins Hospital experience. Stroke 10.1161/STROKEAHA.107.505404
Acknowledgements
The authors would like to thank Drs Neil Miller, Eric Aldrich, Kieran Murphy, Phillip Gailloud and Rebecca Gottesman for contributing information about the study on superselective intra-arterial thrombolysis at the Johns Hopkins Hospital, Baltimore, MD, USA. Dr Chen was supported by the American Australian Association Education Fellowship Program and the Donegan Fund for AION Research at the Wilmer Eye Institute during her fellowship at Johns Hopkins Hospital.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Chen, C., Lee, A. Management of acute central retinal artery occlusion. Nat Rev Neurol 4, 376–383 (2008). https://doi.org/10.1038/ncpneuro0811
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0811
This article is cited by
-
Ocular Complications Following Autologous Fat Injections into Facial Area: Case Report of a Recovery from Visual Loss After Ophthalmic Artery Occlusion and a Review of the Literature
Aesthetic Plastic Surgery (2017)
-
Retinal artery occlusion by left atrial myxoma misdiagnosed as thrombus
SpringerPlus (2016)
-
Anterior chamber paracentesis after central retinal artery occlusion: a tenable therapy?
BMC Ophthalmology (2014)
-
A review of central retinal artery occlusion: clinical presentation and management
Eye (2013)
-
Treatment Options for Central Retinal Artery Occlusion
Current Treatment Options in Neurology (2013)